These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3532255)

  • 41. Diulo.
    Med Lett Drugs Ther; 1979 May; 21(9):40. PubMed ID: 449846
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 43. [International multicentre-study on indapamide in the treatment f essential arterial hypertension (author's transl)].
    Passeron J
    Schweiz Rundsch Med Prax; 1982 Feb; 71(7):293-6. PubMed ID: 7050963
    [No Abstract]   [Full Text] [Related]  

  • 44. New diuretics - bumetanide and metolazone.
    Drug Ther Bull; 1974 Jun; 12(13):49-51. PubMed ID: 4616810
    [No Abstract]   [Full Text] [Related]  

  • 45. Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration.
    Lindroos M; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):643-5. PubMed ID: 6396239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of cyclothiazide and hydrochlorthiazide in hypertension. Effects of different doses of diuretics.
    Jounela AJ; Juustila H; Lilja M
    Cor Vasa; 1985; 27(6):412-6. PubMed ID: 3912112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antihypertensive and hypokalemic effects of isobutyl hydrochlorothiazide alone and in combination with spironolactone.
    Lochaya S; Suvachittanont O; Triyanond K
    J Med Assoc Thai; 1985 Aug; 68(8):399-407. PubMed ID: 3906011
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical experience with metolazone--a new diuretic--in cases of edema and ascites due to hepatic cirrhosis, C.C.F., and malnutrition.
    Sheth UK; Mehta JM; Paul T; Nair S; Sanghvi B
    J Postgrad Med; 1977 Oct; 23(4):147-55. PubMed ID: 615260
    [No Abstract]   [Full Text] [Related]  

  • 49. Metolazone, a diuretic agent.
    Stern A
    Am Heart J; 1976 Feb; 91(2):262-3. PubMed ID: 1246936
    [No Abstract]   [Full Text] [Related]  

  • 50. [Long term therapy of essential hypertension with indapamide: studies on the effect on electrolyte balance and glucose metabolism].
    Zorn J
    Fortschr Med; 1980 Dec; 98(46):1836-40. PubMed ID: 7274922
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical and biochemical evaluation of a new diuretic agent (Metolazone).
    Keogh B; Carmody M; Malone D; O'Dwyer WF
    J Ir Med Assoc; 1971 May; 64(412):255-60. PubMed ID: 5579602
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of verapamil in arterial hypertension].
    Carrasco RM; Luna RL; Rocha MC
    Arq Bras Cardiol; 1979 Mar; 32(3):207-11. PubMed ID: 475607
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical evaluation of metolazone in edematogenic syndromes].
    Arosio E; Pancera P; Apolloni E; Covi G; Lechi A
    Clin Ter; 1984 Dec; 111(5):435-42. PubMed ID: 6240370
    [No Abstract]   [Full Text] [Related]  

  • 54. [Electrolyte balance, plasma renin concentration and reaction of blood pressure in patients with essential hypertension and control subjects during therapy with metolazone, a new diuretic].
    Hayduk K; Riegger G; Krause DK; Kaufmann W
    Arzneimittelforschung; 1974 Jan; 24(1):104-7. PubMed ID: 4406095
    [No Abstract]   [Full Text] [Related]  

  • 55. [Oxprenolol in the treatment of essential arterial hypertension].
    Soto Rojas G
    Prensa Med Mex; 1976; 41(5-6):188-93. PubMed ID: 792867
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical and laboratory study of a new diuretic agent ("vectren") in pregnancy: a comparison with a diuretic agent in current use ("enduron").
    Mackay EV; Khoo SK
    Med J Aust; 1969 Mar; 1(12):607-12. PubMed ID: 4889612
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical evaluation of SE 1520 in the treatment of hypertension.
    Seedat YK; Reddy J
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):275-80. PubMed ID: 4208341
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of mefruside treatment in hypertension.
    Henningsen NC; Bergengren B; Malmborg O; Pihl O; Renmarker K; Strand L
    Acta Med Scand; 1980; 208(4):272-8. PubMed ID: 7446207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Etozolin in the treatment of essential arterial hypertension of mild-to-moderate degree].
    Salerno L; Pepe S; Salli L; Curiale B; Agnello C; Ferraro A
    Minerva Cardioangiol; 1988; 36(1-2):43-8. PubMed ID: 3386853
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C; Mantellini R; Fanti P; Sciarra F
    Minerva Med; 1983 Apr; 74(14-15):791-7. PubMed ID: 6339999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.